XTI Aerospace, Inc. (XTIA) - Q3 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2024. XTI Aerospace, Inc. (formerly Inpixon) completed a reverse merger with Legacy XTI on March 12, 2024. The company operates in two segments: Commercial Aviation (pre-revenue development of the TriFan 600 VTOL aircraft) and Industrial IoT (Real-Time Location Systems, or RTLS). The financial statements reflect the combined entity, with Legacy XTI treated as the accounting acquirer.
Key Financial Metrics
| Metric | Q3 2024 (3 Months) | YTD 2024 (9 Months) | YTD 2023 (9 Months) |
|---|---|---|---|
| Revenue | $0.92 million | $2.17 million | $0 |
| Gross Profit | $0.52 million | $1.32 million | $0 |
| Net Loss | $(4.44) million | $(21.75) million | $(8.90) million |
| Net Loss Attributable to Common | $(4.67) million | $(22.76) million | $(8.90) million |
| Cash and Cash Equivalents | $0.51 million | $0.51 million (End of Period) | $0.24 million (End of Period) |
| Working Capital Deficit | $(11.9) million | $(11.9) million | $(13.0) million |
| Total Debt (Short + Long Term) | $2.69 million | $2.69 million | $25.24 million |
Note: Revenue is derived entirely from the Industrial IoT segment. The Commercial Aviation segment remains pre-revenue.
Material Changes vs. Prior Period
- Revenue Generation: The company transitioned from zero revenue in 2023 to $2.17 million YTD 2024, driven by the inclusion of the Industrial IoT segment post-merger.
- Expense Surge: Operating expenses increased significantly to $28.3 million YTD 2024 (vs. $7.7 million in 2023). This includes $6.5 million in merger-related transaction costs and $6.7 million in transaction bonuses.
- Debt Restructuring: Total debt decreased from $25.2 million at year-end 2023 to $2.7 million at Q3 2024. Approximately $16.8 million in convertible notes were converted to equity immediately prior to the merger closing.
- Non-Cash Items: The YTD 2024 net loss includes a $12.9 million gain from the change in fair value of convertible notes (prior to conversion) and a $6.7 million inducement loss on debt conversions.
Guidance, Outlook, Risks, and Unusual Items
- Liquidity and Going Concern: Management has raised substantial doubt about the company's ability to continue as a going concern. With only $0.5 million in cash and a working capital deficit of $11.9 million, the company requires additional financing to fund operations into Q2 2025.
- Nasdaq Delisting Risk: The company received a "Low Price Deficiency Letter" from Nasdaq on November 7, 2024, due to the stock trading at $0.10 or less for 10 consecutive days. Nasdaq has determined to delist the securities unless an appeal is successful. The company has requested a hearing.
- Legal Proceedings:
- Xeriant Matter: Xeriant Inc. filed a lawsuit alleging breach of contract and fraud regarding the TriFan 600 development, seeking damages in excess of $500 million.
- Chardan Arbitration: Chardan Capital Markets initiated arbitration alleging unpaid fees totaling approximately $1 million and seeking unspecified amounts related to banking services.
- Unusual Items: Significant non-cash stock-based compensation ($3.8 million YTD) and transaction bonuses ($6.7 million YTD) impacted the bottom line. The company also recognized a $0.04 million inventory impairment charge in Q3.
Investor Verification Checklist
- Cash Runway: Verify the sufficiency of the $0.5 million cash balance against the $14.3 million cash burn from operations YTD 2024.
- Financing Constraints: Review the restrictions on the At-The-Market (ATM) offering imposed by Series 9 Preferred Stock holders, which limit sales to $6 million without further consent.
- Debt Covenants: Examine the terms of the secured promissory notes with Streeterville Capital, LLC, which are secured by all Legacy XTI assets and stock and include monthly redemption options.
- Legal Exposure: Assess the potential financial impact of the Xeriant lawsuit ($500M+ claim) and Chardan arbitration, noting the company's inability to estimate potential losses.
- Listing Status: Monitor the outcome of the Nasdaq appeal hearing regarding the low stock price deficiency.